Odys-SI Screw
Medyssey Co., Ltd. · Decision date Oct 15, 2026
What did the FDA decide?
The FDA's 510(k) database records K262522 for the Odys-SI Screw, submitted by Medyssey Co, Ltd. of Jecheon-Si, KR. The device falls under the classification name Sacroiliac Joint Fixation, regulation number 888.3040, product code OUR, with the Orthopedic medical specialty and Orthopedic review panel. The application is listed as a Traditional 510(k), received 07/22/2026, and was not reviewed by a third party, not a combination product, and had no authorized Predetermined Change Control Plan.
On 10/15/2026 the agency recorded a decision of Substantially Equivalent (SESE), which for a 510(k) means clearance to market rather than PMA approval. The public record does not include the cleared indications, the predicate device, or any summary of the technological comparison, so the specific intended use and the basis for the equivalence finding remain unknown from this source. No clinical or performance conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262522
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Medyssey Co., Ltd.
- Product code
- OUR
- Decision code
- SESE
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sacroiliac Joint Fixation.
- Applicant
- Medyssey Co., Ltd.
- Product code
- OUR
- FDA device class
- 2
FDA decision timeline
K262522 received
Application receipt date recorded by FDA.
K262522 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medyssey Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Jecheon-Si
Sources and methodology
- Original FDA record: K262522
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records